The present study was designed to elucidate the role of
p38 mitogen-activated protein kinase (p38) in the pathogenesis of
inflammation, using a mouse
contact hypersensitivity (CHS) model induced by 2,4-dinitro-1-fluorobenzene (
DNFB). Ear swelling was induced by challenge with
DNFB, accompanied by infiltration of mononuclear cells, neutrophils, and eosinophils and a marked increase in
mRNA levels of
cytokines such as
interleukin (IL)-2,
interferon (IFN)-gamma,
IL-4,
IL-5, IL-1beta,
IL-18, and
tumor necrosis factor-alpha in the challenged ear skin. Both ear swelling and the number of infiltrated cells in
DNFB-challenged ear skin were significantly inhibited by treatment with
SB202190, a p38 inhibitor. Furthermore, the
DNFB-induced expression of all
cytokines except
IL-4 was significantly inhibited by treatment with
SB202190.
Ribonuclease protection assay revealed that the
mRNA levels of
chemokines such as IP-10 and MCP-1 in ear skin were markedly increased at 24 h after challenge with
DNFB. The induction of these
chemokines was significantly inhibited by treatment with
SB202190. In p38alpha +/- mice, both ear swelling and infiltration of cells induced by
DNFB were reduced compared with those in wild-type mice. However, induction of
cytokines by
DNFB was also observed in p38alpha +/- mice, although the induction of IFN-gamma,
IL-5, and
IL-18 was typically reduced compared with that in wild-type mice. Challenge with
DNFB slightly induced IP-10 and MCP-1
mRNA in p38alpha +/- mice, with weaker signals than those in SB202190-treated wild-type mice. These results suggest that p38 plays a key role in CHS and is an important target for the treatment of CHS.